vs

Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and GLOBAL INDUSTRIAL Co (GIC). Click either name above to swap in a different company.

CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $345.6M, roughly 1.4× GLOBAL INDUSTRIAL Co). GLOBAL INDUSTRIAL Co runs the higher net margin — 4.2% vs -10.1%, a 14.3% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 14.3%). GLOBAL INDUSTRIAL Co produced more free cash flow last quarter ($19.2M vs $-69.0M). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 3.4%).

Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.

Global Industrial Company is a Port Washington, New York–based company providing industrial and MRO products through a system of branded e-Commerce websites and relationship marketers in North America. The primary brand is Global Industrial.

CLOV vs GIC — Head-to-Head

Bigger by revenue
CLOV
CLOV
1.4× larger
CLOV
$487.7M
$345.6M
GIC
Growing faster (revenue YoY)
CLOV
CLOV
+30.4% gap
CLOV
44.7%
14.3%
GIC
Higher net margin
GIC
GIC
14.3% more per $
GIC
4.2%
-10.1%
CLOV
More free cash flow
GIC
GIC
$88.2M more FCF
GIC
$19.2M
$-69.0M
CLOV
Faster 2-yr revenue CAGR
CLOV
CLOV
Annualised
CLOV
18.6%
3.4%
GIC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLOV
CLOV
GIC
GIC
Revenue
$487.7M
$345.6M
Net Profit
$-49.3M
$14.6M
Gross Margin
34.5%
Operating Margin
-10.1%
5.7%
Net Margin
-10.1%
4.2%
Revenue YoY
44.7%
14.3%
Net Profit YoY
-123.2%
36.4%
EPS (diluted)
$0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLOV
CLOV
GIC
GIC
Q4 25
$487.7M
$345.6M
Q3 25
$496.6M
$353.6M
Q2 25
$477.6M
$358.9M
Q1 25
$462.3M
$321.0M
Q4 24
$337.0M
$302.3M
Q3 24
$331.0M
$342.4M
Q2 24
$356.3M
$347.8M
Q1 24
$346.9M
$323.4M
Net Profit
CLOV
CLOV
GIC
GIC
Q4 25
$-49.3M
$14.6M
Q3 25
$-24.4M
$18.8M
Q2 25
$-10.6M
$25.1M
Q1 25
$-1.3M
$13.6M
Q4 24
$-22.1M
$10.7M
Q3 24
$-9.2M
$16.8M
Q2 24
$7.4M
$20.3M
Q1 24
$-19.2M
$13.2M
Gross Margin
CLOV
CLOV
GIC
GIC
Q4 25
34.5%
Q3 25
35.6%
Q2 25
37.1%
Q1 25
34.9%
Q4 24
33.8%
Q3 24
24.5%
34.0%
Q2 24
30.3%
35.2%
Q1 24
23.6%
34.3%
Operating Margin
CLOV
CLOV
GIC
GIC
Q4 25
-10.1%
5.7%
Q3 25
-4.9%
7.4%
Q2 25
-2.2%
9.3%
Q1 25
-0.3%
5.7%
Q4 24
-6.4%
4.8%
Q3 24
-2.7%
6.5%
Q2 24
2.0%
7.6%
Q1 24
-6.5%
5.4%
Net Margin
CLOV
CLOV
GIC
GIC
Q4 25
-10.1%
4.2%
Q3 25
-4.9%
5.3%
Q2 25
-2.2%
7.0%
Q1 25
-0.3%
4.2%
Q4 24
-6.6%
3.5%
Q3 24
-2.8%
4.9%
Q2 24
2.1%
5.8%
Q1 24
-5.5%
4.1%
EPS (diluted)
CLOV
CLOV
GIC
GIC
Q4 25
$0.37
Q3 25
$0.48
Q2 25
$0.65
Q1 25
$0.35
Q4 24
$0.28
Q3 24
$0.44
Q2 24
$0.52
Q1 24
$0.34

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLOV
CLOV
GIC
GIC
Cash + ST InvestmentsLiquidity on hand
$78.3M
$67.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$308.7M
$313.2M
Total Assets
$541.0M
$580.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLOV
CLOV
GIC
GIC
Q4 25
$78.3M
$67.5M
Q3 25
$67.2M
Q2 25
$55.1M
Q1 25
$39.0M
Q4 24
$194.5M
$44.6M
Q3 24
$288.0M
$38.9M
Q2 24
$254.8M
$38.8M
Q1 24
$208.3M
$29.9M
Stockholders' Equity
CLOV
CLOV
GIC
GIC
Q4 25
$308.7M
$313.2M
Q3 25
$340.9M
$316.0M
Q2 25
$344.2M
$305.2M
Q1 25
$336.1M
$287.9M
Q4 24
$341.1M
$281.1M
Q3 24
$342.2M
$279.2M
Q2 24
$324.9M
$270.4M
Q1 24
$292.5M
$260.2M
Total Assets
CLOV
CLOV
GIC
GIC
Q4 25
$541.0M
$580.8M
Q3 25
$559.7M
$602.5M
Q2 25
$575.0M
$586.5M
Q1 25
$583.7M
$536.7M
Q4 24
$580.7M
$520.7M
Q3 24
$653.0M
$531.6M
Q2 24
$674.2M
$542.5M
Q1 24
$671.8M
$517.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLOV
CLOV
GIC
GIC
Operating Cash FlowLast quarter
$-66.9M
$20.0M
Free Cash FlowOCF − Capex
$-69.0M
$19.2M
FCF MarginFCF / Revenue
-14.1%
5.6%
Capex IntensityCapex / Revenue
0.4%
0.2%
Cash ConversionOCF / Net Profit
1.37×
TTM Free Cash FlowTrailing 4 quarters
$-69.2M
$74.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLOV
CLOV
GIC
GIC
Q4 25
$-66.9M
$20.0M
Q3 25
$12.1M
$22.7M
Q2 25
$5.4M
$31.7M
Q1 25
$-16.3M
$3.4M
Q4 24
$34.8M
$15.9M
Q3 24
$50.0M
$9.6M
Q2 24
$44.8M
$18.8M
Q1 24
$25.9M
$6.4M
Free Cash Flow
CLOV
CLOV
GIC
GIC
Q4 25
$-69.0M
$19.2M
Q3 25
$11.4M
$22.0M
Q2 25
$4.8M
$30.3M
Q1 25
$-16.5M
$3.2M
Q4 24
$33.3M
$15.2M
Q3 24
$49.6M
$8.7M
Q2 24
$44.4M
$17.9M
Q1 24
$25.5M
$5.1M
FCF Margin
CLOV
CLOV
GIC
GIC
Q4 25
-14.1%
5.6%
Q3 25
2.3%
6.2%
Q2 25
1.0%
8.4%
Q1 25
-3.6%
1.0%
Q4 24
9.9%
5.0%
Q3 24
15.0%
2.5%
Q2 24
12.5%
5.1%
Q1 24
7.3%
1.6%
Capex Intensity
CLOV
CLOV
GIC
GIC
Q4 25
0.4%
0.2%
Q3 25
0.1%
0.2%
Q2 25
0.1%
0.4%
Q1 25
0.0%
0.1%
Q4 24
0.5%
0.2%
Q3 24
0.1%
0.3%
Q2 24
0.1%
0.3%
Q1 24
0.1%
0.4%
Cash Conversion
CLOV
CLOV
GIC
GIC
Q4 25
1.37×
Q3 25
1.21×
Q2 25
1.26×
Q1 25
0.25×
Q4 24
1.49×
Q3 24
0.57×
Q2 24
6.04×
0.93×
Q1 24
0.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons